Schonfeld Strategic Advisors LLC 10x Genomics, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 25,220 shares of TXG stock, worth $381,830. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,220
Previous 32,697
22.87%
Holding current value
$381,830
Previous $1.23 Million
60.07%
% of portfolio
0.0%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding TXG
# of Institutions
287Shares Held
95.8MCall Options Held
162KPut Options Held
107K-
Vanguard Group Inc Valley Forge, PA10.2MShares$154 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.31MShares$141 Million1.65% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$96.8 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.15MShares$93.1 Million1.4% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.14MShares$93 Million0.09% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.44B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...